In April 2024 : - $NEAR was at a $10.2B - $TAO was at $4.6B. > The gap was over 2X > 2 years later, they are both close to $3B. Is $TAO slowly becoming the leading AI token in web3, or does $NEAR have enough to keep leading? These are the things that actually matter for these two projects: ➠ Market Cap vs FDV TAO only has 45.8% of its supply circulating. NEAR is at ~100%. On a fully diluted basis, TAO is valued at $5.86B vs NEAR's $3.08B. That means TAO is nearly 2x more expensive than NEAR in real terms. The dilution just hasn't hit yet. ➠ 𝗢𝗻-𝗖𝗵𝗮𝗶𝗻 𝗘𝗰𝗼𝗻𝗼𝗺𝗶𝗰𝘀: 𝗡𝗼𝘁 𝗘𝘃𝗲𝗻 𝗖𝗹𝗼𝘀𝗲 NEAR generates 7.6x more app fees per day. $118K average vs TAO's $15.6K. NEAR has $183M in DeFi TVL that nearly tripled over the last 90 days. TAO is not in DeFi NEAR does $134M in daily DEX volume across 37 deployed protocols. TAO has none because it's not built for DeFi. This isn't a knock on TAO by design. Bittensor is an AI incentive network, not a smart contract L1. But the gap in on-chain economic activity is massive. ➠ 𝗧𝗵𝗲 𝗦𝘂𝗯𝘀𝗶𝗱𝘆 𝗕𝗼𝗺𝗯 𝗡𝗼𝗯𝗼𝗱𝘆 𝗧𝗮𝗹𝗸𝘀 𝗔𝗯𝗼𝘂𝘁 Bittensor pays over $148M per year in emissions to miners and validators. It generates only $3M to $15M in real external revenue. That's a subsidy-to-revenue ratio of 10x to 50x. The top subnet, SN64 Chutes, has 400K+ users and 9 trillion tokens processed. Still running at a 22:1 to 40:1 subsidy ratio. For every $1 of organic revenue, Bittensor is printing $10 to $50 in emissions. This only works if token price keeps going up to compensate. The moment buyer demand stalls, the economics unravel. NEAR's subsidies are roughly in line with what the protocol earns. Subsidy-to-revenue ratio sits around 1x. Real fees from real users. ➠ 𝗩𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗦𝗮𝗻𝗶𝘁𝘆 𝗖𝗵𝗲𝗰𝗸 Using 30-day fees annualized: NEAR P/F ratio = 87x. Expensive, but real fees exist to back it. TAO P/F ratio = 447x. Priced almost entirely on narrative. That's a 5x premium for TAO over NEAR on a price-to-fees basis with half the supply still locked. ➠ 𝗟𝗶𝗾𝘂𝗶𝗱𝗶𝘁𝘆 𝗠𝗮𝘁𝘁𝗲𝗿𝘀 𝗠𝗼𝗿𝗲 𝗧𝗵𝗮𝗻 𝗬𝗼𝘂 𝗧𝗵𝗶𝗻𝗸 NEAR's 24h trading volume runs at $1.1B. TAO sits at $246M. Vol/mcap turnover of 35.5% vs 9.2%. If you're deploying any real size, NEAR is 4x easier to enter and exit without getting wrecked on slippage. ➠ 𝗕𝘂𝘁 𝗧𝗔𝗢 𝗛𝗮𝘀 𝗢𝗻𝗲 𝗧𝗵𝗶𝗻𝗴 𝗡𝗘𝗔𝗥 𝗗𝗼𝗲𝘀𝗻'𝘁: 𝗘𝗧𝗙 𝗖𝗮𝘁𝗮𝗹𝘆𝘀𝘁𝘀 Both Grayscale and Bitwise filed for spot TAO ETFs in April 2026. SEC decision expected August 2026. Grayscale has already pushed TAO to 43% weight in its Decentralized AI Fund, an all-time high. This is TAO's one genuine binary catalyst. If approved, it compresses the discount to institutional demand meaningfully. NEAR has no equivalent catalyst. ➠ 𝗔𝗧𝗛 𝗗𝗶𝘀𝘁𝗮𝗻𝗰𝗲: 𝗧𝘄𝗼 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗦𝘁𝗼𝗿𝗶𝗲𝘀 TAO needs a 2.7x rally to reclaim its ATH of $757. That ATH was only set in March 2024. More achievable. NEAR needs an 8.6x rally to hit its ATH of $20.44 from January 2022. Much higher bar, but also means it's significantly more beaten up relative to its prior peak. More upside if the cycle returns. ➠ 𝗧𝗵𝗲 𝗕𝗼𝘁𝘁𝗼𝗺 𝗟𝗶𝗻𝗲 NEAR wins on every measurable on-chain metric. Fees, volume, TVL growth, ecosystem depth, fee sustainability. It's a fundamentals story that needs a full bull cycle to unlock. TAO wins the narrative game. AI, ETF optionality, 128 specialized subnets. But it's burning 10x more than it earns, just had a governance crisis, and has 54% of its total supply still to come. Same market cap. Completely different risk profiles. You're choosing between a working economy with a slower narrative, and a compelling narrative with a fragile economy.

Share







Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.
